E-cigarette use associated with risk of cardiovascular events, study finds
The data is "a real wake-up call and should prompt more action and awareness about the dangers of e-cigarettes,” said Mohinder Vindhyal, M.D., M.Ed., assistant professor at the University of Kansas School of Medicine-Wichita and the study’s lead author.

A study led by a KU School of Medicine-Wichita faculty member found that e-cigarette use is associated with an increased risk for heart attack, coronary artery disease and depression.
The research led by Mohinder Vindhyal, M.D., M.Ed., was presented at the American College of Cardiology's 68th Annual Scientific Session, with details shared in an ACC press release that prompted international news headlines. Adults who report puffing e-cigarettes, or vaping, are significantly more likely to have a heart attack, coronary artery disease and depression compared with those who don't use them or any tobacco products, according to the study findings.
"Until now, little has been known about cardiovascular events relative to e-cigarette use," Dr. Vindhyal, assistant professor in Internal Medicine at KU School of Medicine-Wichita, stated in the ACC release. "These data are a real wake-up call and should prompt more action and awareness about the dangers of e-cigarettes."
E-cigarettes are battery-operated, handheld devices that mimic the experience of smoking a cigarette. They work by heating the e-liquid, which may contain a combination of nicotine, solvent carriers (glycerol, propylene and/or ethylene glycol) and any number of flavors and other chemicals, to a high enough temperature to create an aerosol, or "vapor," that is inhaled and exhaled. According to Vindhyal, there are now more than 460 brands of e-cigarettes and over 7,700 flavors.
This study found that compared with nonusers, e-cigarette users were 56 percent more likely to have a heart attack and 30 percent more likely to suffer a stroke, according to the release. Coronary artery disease and circulatory problems, including blood clots, were also much higher among those who vape-10 percent and 44 percent higher, respectively. This group was also twice as likely to suffer from depression, anxiety and other emotional problems.
Most, but not all, of these associations held true when controlling for other known cardiovascular risk factors, such as age, sex, body mass index, high cholesterol, high blood pressure and smoking. After adjusting for these variables, e-cigarette users were 34 percent more likely to have a heart attack, 25 percent more likely to have coronary artery disease and 55 percent more likely to suffer from depression or anxiety, the release states. Stroke, high blood pressure and circulatory problems were no longer statistically different between the two groups.
"When the risk of heart attack increases by as much as 55 percent among e-cigarettes users compared to nonsmokers, I wouldn't want any of my patients nor my family members to vape," Dr. Vindhyal said in the release. "When we dug deeper, we found that regardless of how frequently someone uses e-cigarettes, daily or just on some days, they are still more likely to have a heart attack or coronary artery disease."
The study, one of the largest to date looking at the relationship between e-cigarette use and cardiovascular and other health outcomes and among the first to establish an association. The findings were spotlighted in a Popular Science article, which referenced another study led by Paul Ndunda, M.D., also an assistant professor in Internal Medicine at KU School of Medicine-Wichita.
The study led by Dr. Vindhyal included data from a total of 96,467 respondents from the National Health Interview Survey, a Centers for Disease Control and Prevention-fielded survey of Americans, from 2014, 2016 and 2017. The 2015 survey did not include any e-cigarette-related questions. In their analyses, researchers looked at the rates of high blood pressure, heart attack, stroke, coronary artery disease, diabetes and depression/anxiety among those who reported using e-cigarettes (either some days or daily) and nonusers. Those who reported using e-cigarettes were younger than nonusers (33 years of age on average vs. 40.4 years old), according to the ACC release.
Researchers also compared the data for reported tobacco smokers and nonsmokers. Traditional tobacco cigarette smokers had strikingly higher odds of having a heart attack, coronary artery disease and stroke compared with nonsmokers-a 165, 94 and 78 percent increase, respectively, according to the ACC release. They were also significantly more likely to have high blood pressure, diabetes, circulatory problems, and depression or anxiety.
The researchers looked at health outcomes by how often someone reported using e-cigarettes, either "daily" or "some days." When compared to non-e-cigarette users, daily e-cigarette users had higher odds of heart attack, coronary artery disease and depression/anxiety, whereas some days users were more likely to have a heart attack and suffer from depression/anxiety, with only a trend toward coronary artery disease, the ACC release states. Researchers said this could be due to decreased toxic effects of e-cigarette usage, early dissipation of the toxic effects, or the fact that it has not been studied long enough to show permanent damage to portray cardiovascular disease morbidity.
"Cigarette smoking carries a much higher probability of heart attack and stroke than e-cigarettes, but that doesn't mean that vaping is safe," Dr. Vindhyal said, adding that some e-cigarettes contain nicotine and release very similar toxic compounds to tobacco smoking. Nicotine can quicken heart rate and raise blood pressure.
There are some limitations. For example, the study design doesn't allow researchers to establish causation, but Dr. Vindhyal said in the release that it does show a clear association between any kind of smoking and negative health outcomes. He added that self-reported data is also subject to recall bias. The researchers were also unable to determine whether these outcomes may have occurred prior to using e-cigarettes, according to the ACC release. Further longitudinal data is needed.